# A Study of Teduglutide (Revestive®) in Children, Teenagers and Adults With Short Bowel Disease

> **NCT04877431** · — · COMPLETED · sponsor: **Takeda** · enrollment: 45 (actual)

## Conditions studied

- Short Bowel Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04877431
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-05
- **Primary completion:** 2023-06-05
- **Final completion:** 2023-06-05
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2023-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04877431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04877431, "A Study of Teduglutide (Revestive®) in Children, Teenagers and Adults With Short Bowel Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04877431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*